Article
XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Aug 2011
Vaezi Alec, Wang Xiaozhe, Buch Shama, Gooding William, Wang Lin, Seethala Raja R, Weaver David T, D'Andrea Alan D, Argiris Athanassios, Romkes Marjorie, Niedernhofer Laura J, Grandis Jennifer R
Abstract excerpt
PURPOSE: Tumor-specific biomarkers that predict resistance to DNA damaging agents may improve therapeutic outcomes by guiding the selection of effective therapies and limiting morbidity related to ineffective approaches. XPF (ERCC4) is an essential component of several DNA repair pathways and XPF-deficient cells are exquisitely sensitive to DNA damaging agents. The purpose of this study was to determine whether...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
